Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Antibody-based selective isolation of atrial and ventricular cardiomyocytes by differential expression of integrin α6 (CD49f)


ABSTRACT: Central questions like cardiomyocyte subtype emergence during cardiogenesis or availability of cardiomyocyte subtypes for cell replacement therapy require selective identification and purification of atrial and ventricular cardiomyocytes. However, characterization and implementation of pure cardiomyocyte subtypes is still challenging due to technical limitations. Our aim was to identify surface markers enabling the selective detection and purification of atrial and ventricular cardiomyocytes from mouse hearts. In a surface marker screen we found differential expression of CD49f in atrial and ventricular embryonic cardiomyocytes (E13.5). By flow cytometry we could correlate a high CD49f expression with MLC-2a on the single cell level; a low CD49f expression corresponded to MLC-2v. Based on the persisting differential CD49f expression we developed purification protocols for cardiomyocytes subtypes from the developing mouse heart. Flow sorting of E15.5 hearts into ErbB-2+/CD49flow and ErbB-2+/CD49fhigh cells led to a selective depletion (CD49flow) or enrichment of MLC-2a+ cells (CD49fhigh). We found a corresponding CD49f-dependent distribution of MLC-2a when pre-enriched neonatal cardiomyocytes (P2) were flow-sorted into CD49flow and CD49fhigh. Atrial and ventricular identity was confirmed by expression profiling and patch clamp analysis of sorted embryonic hearts, which unequivocally demonstrated that the sorted cells were viable and functional. For the first time, we introduce a non-genetic, antibody-based approach to specifically isolate atrial and ventricular cardiomyocytes from mouse hearts of various developmental stages. This newly gained capability of obtaining highly pure, viable cells will facilitate in-depths characterization of the individual cellular subsets and will aid translational research and therapeutic applications. The dataset comprises four different cardiomyocytes subtypes from the developing mouse heart. Embryonic (E15.5) hearts were dissociated and flow-sorted into ErbB-2+/CD49flow and ErbB-2+/CD49fhigh cardiomyocytes. Neonatal (P2) hearts were dissociated, contaminating non-myocytes were removed by MACS depletion, and the purified cardiomyocytes were flow-sorted into CD49flow and CD49fhigh cardiomyocytes. Four biological replicates were available for each sample groups. Microarray analysis was conducted on the Agilent Whole Mouse Genome Oligo Microarray 8x60K platform.

ORGANISM(S): Mus musculus

SUBMITTER: Stefan Tomiuk 

PROVIDER: E-GEOD-57131 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Differential Expression Levels of Integrin α6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes.

Wiencierz Anne Maria AM   Kernbach Manuel M   Ecklebe Josephine J   Monnerat Gustavo G   Tomiuk Stefan S   Raulf Alexandra A   Christalla Peter P   Malan Daniela D   Hesse Michael M   Bosio Andreas A   Fleischmann Bernd K BK   Eckardt Dominik D  

PloS one 20151130 11


<h4>Rationale</h4>Central questions such as cardiomyocyte subtype emergence during cardiogenesis or the availability of cardiomyocyte subtypes for cell replacement therapy require selective identification and purification of atrial and ventricular cardiomyocytes. However, current methodologies do not allow for a transgene-free selective isolation of atrial or ventricular cardiomyocytes due to the lack of subtype specific cell surface markers.<h4>Methods and results</h4>In order to develop cell s  ...[more]

Similar Datasets

2015-12-14 | GSE57131 | GEO
2023-01-25 | MSV000091143 | MassIVE
2010-05-14 | E-GEOD-17294 | biostudies-arrayexpress
2010-06-10 | E-GEOD-7162 | biostudies-arrayexpress
2022-05-19 | PXD014317 | Pride
2024-08-09 | PXD038300 | Pride
2019-06-19 | GSE128688 | GEO
2011-11-30 | E-GEOD-29819 | biostudies-arrayexpress
2023-01-05 | GSE219000 | GEO
2022-01-30 | E-MTAB-9256 | biostudies-arrayexpress